These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 25188901)
21. Effects of epoxyeicosatrienoic acids (EETs) on retinal macular degeneration in rat models. Mei F; Wang JG; Chen ZJ; Yuan ZL Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2970-2979. PubMed ID: 28682418 [TBL] [Abstract][Full Text] [Related]
22. Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovascularization model. Lin X; Wang Q; He M Exp Eye Res; 2019 Jul; 184():1-7. PubMed ID: 30928489 [TBL] [Abstract][Full Text] [Related]
23. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA. Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283 [TBL] [Abstract][Full Text] [Related]
24. Optimization of laser-induced choroidal neovascularization in African green monkeys. Goody RJ; Hu W; Shafiee A; Struharik M; Bartels S; López FJ; Lawrence MS Exp Eye Res; 2011 Jun; 92(6):464-72. PubMed ID: 21414311 [TBL] [Abstract][Full Text] [Related]
25. The Antiangiogenic Effects of Gold Nanoparticles on Experimental Choroidal Neovascularization in Mice. Roh YJ; Rho CR; Cho WK; Kang S Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6561-6567. PubMed ID: 27918830 [TBL] [Abstract][Full Text] [Related]
26. Fiji-Assisted Automatic Quantitative Volumetric Analysis of Choroidal Neovascularization in a Laser-Induced Choroidal Neovascularization Mouse Model. Pollalis D; Nanda AV; Nair GKG; Lee SY Transl Vis Sci Technol; 2023 Apr; 12(4):10. PubMed ID: 37043336 [TBL] [Abstract][Full Text] [Related]
27. Correlation of CD105 and vascular endothelial growth factor in laser-induced choroidal neovascularization in rats. Xu J; Wang Y; Yang X; Zhang P; Chen L Yan Ke Xue Bao; 2006 Sep; 22(3):166-74, 183. PubMed ID: 17162902 [TBL] [Abstract][Full Text] [Related]
28. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Edelman JL; Castro MR Exp Eye Res; 2000 Nov; 71(5):523-33. PubMed ID: 11040088 [TBL] [Abstract][Full Text] [Related]
29. Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Laser-Induced Choroidal Neovascularization in Mice. Ozone D; Mizutani T; Nozaki M; Ohbayashi M; Hasegawa N; Kato A; Yasukawa T; Ogura Y Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5348-5354. PubMed ID: 27727399 [TBL] [Abstract][Full Text] [Related]
30. A novel imaging technique for experimental choroidal neovascularization. Campos M; Amaral J; Becerra SP; Fariss RN Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5163-70. PubMed ID: 17122098 [TBL] [Abstract][Full Text] [Related]
31. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor. Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982 [TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model. Ishida K; Yoshimura N; Mandai M; Honda Y Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1512-9. PubMed ID: 10359334 [TBL] [Abstract][Full Text] [Related]
34. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes. Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT Mol Vis; 2013; 19():54-61. PubMed ID: 23335851 [TBL] [Abstract][Full Text] [Related]
35. Anti-VEGFR2 Antibody-modified Micelle for Triggered Drug Delivery and Effective Therapy of Choroidal Neovascularization. Takahashi K; Masuda T; Harada M; Inoue T; Nakamura S; Naito K; Hara H; Shimazawa M Curr Neurovasc Res; 2019; 16(3):258-265. PubMed ID: 31258081 [TBL] [Abstract][Full Text] [Related]
36. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression. Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat. Kamizuru H; Kimura H; Yasukawa T; Tabata Y; Honda Y; Ogura Y Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2664-72. PubMed ID: 11581214 [TBL] [Abstract][Full Text] [Related]
38. Pirfenidone ameliorates the formation of choroidal neovascularization in mice. Bao Y; Huang L; Huang X; Gao C; Chen Y; Wu L; Zhu S; Song Y Mol Med Rep; 2020 May; 21(5):2162-2170. PubMed ID: 32323767 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects between intravitreal and periocular injections of adenoviral vectored pigment epithelium-derived factor on suppressing choroidal neovascularization in rats. Yan H; Cui J; Wang Y; Yu Y Ophthalmic Res; 2013; 49(2):81-9. PubMed ID: 23257710 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Gu L; Chen H; Tuo J; Gao X; Chen L Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]